Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 820M | 882M | 881M | 819M |
Cost of revenue | 612M | 702M | 646M | 594M |
Gross profit | 208M | 179M | 236M | 225M |
Operating expense | ||||
Research & development | 105M | 86M | 95M | 113M |
Selling general and admin | 110M | 116M | 105M | 100M |
Other operating expenses | 2M | 6M | 2M | 10M |
Operating income | -3M | -27M | 50M | 11M |
Non operating interest income | ||||
Income | — | — | 58M | 11M |
Expense | — | — | 92M | 66M |
Other income expense | — | — | — | — |
Pretax income | -66M | -58M | 34M | -39M |
Tax provision | 16M | 0 | 10M | 2M |
Net income | -82M | -58M | 24M | -41M |
Basic EPS | -0.8 | -0.6 | 0.2 | -0.4 |
Diluted EPS | -0.8 | -0.6 | 0.2 | -0.4 |
Basic average shares | 98.8M | 96.6M | 100M | 105M |
Diluted average shares | 98.8M | 96.6M | 100M | 105M |
EBITDA | 89M | 74M | 213M | 111M |
Net income from continuing op. | -82M | -58M | 24M | -41M |
Minority interests | 0 | 1M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |